Sexual Health and HIV Prevention in the State of Colorado

This activity is jointly provided by Postgraduate Institute for Medicine, the Colorado Academy of Family Physicians, and Terranova Medica, LLC in collaboration with the Colorado Health Network.

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

This activity is approved for ABIM Maintenance of Certification Part 2 credit.

Scroll to the bottom of CME information to begin this course.

Release Date: 9/22/2017 Valid through: 9/21/2018

Estimated Time to Complete Activity
1.5 hours

Ronald H. Goldschmidt, MD
Professor of Clinical Family and Community Medicine
Vice-Chair, UCSF Department of Family and Community Medicine
San Francisco, California

Katherine Frasca, MD
Assistant Professor
Division of Infectious Diseases
University of Colorado Denver
Denver, Colorado

Target Audience
Primary care providers and other healthcare professionals who interact with patients at risk for HIV in the state of Colorado.

Educational Objectives
After completing this activity, the participant should be better able to:

  • Conduct an effective sexual health assessment
  • Identify risk groups at sufficiently high risk for HIV to warrant consideration of PrEP
  • Evaluate the indications and appropriate prescribing/monitoring practices for the PrEP regimen
  • Provide PrEP or refer patients at sufficient risk for PrEP regimen
  • Connect patients at risk for HIV in with regional patient support resources

Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, the Colorado Academy of Family Physicians, and Terranova Medica, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Participants will need to provide their unique, six-digit ABIM ID number.

This enduring activity based on a presentation at the 2017 Colorado Academy of Family Physicians Annual Summit, has been reviewed and is acceptable for up to 1.5 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Please contact Erin Watwood should you have any questions regarding AAFP CME credit (

Disclosure of Conflicts of Interest
The Postgraduate Institute for Medicine requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Ronald H. Goldschmidt, MD, and Katherine Frasca, MD, have nothing to disclose.

Dr Goldschmidt reports that the Clinician Consultation Center is supported by the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau – AETCs Centers for Disease Control and Prevention (CDC).

Dr Goldschmidt received no compensation for his work on this initiative.

Peer Reviewers
No real or apparent conflicts of interest to report

Planners and Managers
Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP at PIM; Lisa Tushla, PhD, H (ASCP) at Terranova Medica, LLC; and Erin Watwood at the Colorado Academy of Family Physicians have nothing to disclose.

Instructions for Obtaining Credit

We support green CME by offering your request for CME/CE credit online.  During the period 9/22/2017 through 9/21/2018, to obtain your CME/CE certificate, please follow the steps below:

  1. Go to
  2. Register or Login (will take less than 1 minute)
  3. Type in “12136” at the top of the page, “Find Post-Test/Evaluation by Course”, click enter
  4. Click on activity title when it appears
  5. Choose the type of credit you would like
  6. Complete online Posttest and Evaluation
  7. Receive an immediate CME Certificate to download and/or print for your files

If you have any questions regarding the CME certification for this activity, please contact Postgraduate Institute for Medicine at: or (303) 799-1930.

Computer System Requirements
To participate, you will need access to a computer (either MAC or PC), tablet, or smart phone, with a Chrome (version 22.0.1229.94 or greater) web browser, Firefox (version 3.6 or greater) web browser, or an Internet Explorer (version 8.0 or greater) web browser, JavaScript enabled, connected to the Internet (high speed connection preferred).

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.